SICHUAN BIOKIN PHARMACEUTICAL <688506.SS> SAYS UNIT RECEIVED SECOND MILESTONE PAYMENT OF $250 MLN FROM BRISTOL-MYERS SQUIBB FOR IZA-BREN AGREEMENT

Reuters · 1d ago

Please log in to view news